In CMM10 melanoma cells, the differences between CDK4/6 inhibitor treated cells and control cells were less obvious, although with palbociclib concentrations ≥2.5 μM cell numbers slowly but steadily decreased with increasing concentrations of the compound (Figure 5C). Here, CDK4 is linked to melanoma.